3Hermon MM, Golej J, Burda G, et al. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit[ J]. Shock ,2002,17: 247 -251.
4Lopez-Herce J, de Lucas N, carrillo A, et al. Surfactant treatment for acute respiratory distress syndrome[ J]. Arch Dis Child, 1999,80:248 - 252.
5Haitsma J J, Papadakos P J, Lachmann B. Surfactant therapy for acute lung injury/acute respiratory distress syndrome[ J]. Curr Opin Crit Care, 2004, 10:18 -22.
6Laehmann B, Eijking EP, et al. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function [ J ].Intensive Care Med, 1994, 20:6 - 11.
7Hartog A, Gommem D, Haitsma JJ, et al. Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure[ J]. Br J Anaesth, 2000, 85(5):752 -756.
8McCann UG Ⅱ , Schiller HJ, Carney DE, et al. Visual validation of the mechanical stabilizing effects of positive end-expiratory pressure at the alveolar level[J]. J Surg Res, 2001,99: 335 -342.
9Jeffrey MH, Jay MS, Henry JS, et al. Positive end-expiratory pressure after a recruitment maneuver prevent both alveolar collapse and recruitment/derecruitment[ J]. Am J Respir Crit Care Med, 2003,167:1620 - 1626.
